High Variability in Diagnosis of Dense Breasts

Article

A recent study found that radiologists differ in their interpretation of whether a woman has dense breasts based on mammography.

When examining mammograms, radiologists can differ widely in their interpretation of whether a woman has dense breasts, according to a new study published in Annals of Internal Medicine.

“There is wide variation in density assessment across radiologists that should be carefully considered by providers and policymakers when considering supplemental screening strategies,” wrote study author William E. Barlow, PhD, professor of statistics at the University of Washington School of Public Health, and colleagues. “The likelihood of a woman being told she has dense breasts varies substantially according to which radiologist interprets her mammogram.”

The multicenter observational study compiled data from 83 radiologists, each of whom interpreted at least 500 screening mammograms between 2011 and 2013. The analysis included 216,783 mammograms from over 145,000 women.

Overall the study found that 36.9% of mammograms were from patients with dense breasts, but this rate varied widely across radiologists, from 6.3% to 84.5%. The variation among clinicians in judging breast density was similar regardless of other patient characteristics.

Among women who had multiple mammograms evaluated by different radiologists, 17.2% had disagreeing results, sometimes receiving a dense breast status and sometimes not.

The variability found in this analysis has implications for supplemental screening for women evaluated as having dense breast tissue, according to the authors. Currently, half of the states in the United States have legislation that dictates that women must be told about their breast density status and that additional screening tests should be considered if they have dense breasts.

The issue with such legislature is that the evaluation of breast tissue density using mammography is subjective.

Recently the American College of Radiology released a statement that highlighted the lack of reproducibility in the evaluation of women’s breast density and expressed caution regarding the potential unintended harms that mandatory breast density notification could cause patients.

The results of this study are further evidence that eliminating the subjectivity of breast density evaluation is needed by developing objective and standardized ways to measure the density of breast tissue, the authors noted. Ways to make these evaluations objective include both better training of radiologists and implementing automated density quantification tools.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.